Vivos Therapeutics (VVOS) Income from Non-Controlling Interests (2026)
Vivos Therapeutics (VVOS) reported Income from Non-Controlling Interests of -$42,000 for Q2 2026.
Powered by 
Analysis
Vivos Therapeutics (VVOS) Income from Non-Controlling Interests (2026) Analysis & Trends
For FY2025, Vivos Therapeutics posted Income from Non-Controlling Interests of -$60,000.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn | 5.00 Mn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn | - |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn | - |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn | 5.10 Mn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn | 9.00 Mn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn | - |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn | -2.00 Mn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn | -500,000.00 |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn | - |
| 10 | Vivos Therapeutics | 2.18 Mn | -7.03 Mn | 2.95 Mn | -42,000.00 |
API Access
Vivos Therapeutics Income from Non-Controlling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=VVOS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "VVOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=VVOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();